Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

ViiV Healthcare UK Ltd
Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 23/06/2011
PIL Trizivir film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 18/02/2011 and displayed until 23/06/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 29/06/2010 and displayed until 18/02/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 22/01/2010 and displayed until 29/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change due to user-testing of patient information
Updated on 11/12/2009 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/06/2009 and displayed until 11/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 03/06/2008 and displayed until 30/06/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 30/01/2008 and displayed until 03/06/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 16/02/2007 and displayed until 30/01/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 25/07/2006 and displayed until 16/02/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change to side-effects
Updated on 30/06/2005 and displayed until 25/07/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 15/07/2004 and displayed until 30/06/2005
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to Further Information section
  • Change to date of revision
Updated on 08/03/2004 and displayed until 15/07/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/09/2003 and displayed until 08/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 23/12/2002 and displayed until 01/09/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 17/05/2002 and displayed until 23/12/2002
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  lamivudine
  zidovudine
  abacavir sulfate